Mannitol Content Determination According to the Chinese Pharmacopoeia: Sodium Periodate Titration Me

The Chinese Pharmacopoeia (ChP) designates a sodium periodate oxidation followed by indirect iodometric titration as the official method for mannitol (C6H14O6) content determination in pharmaceutical raw materials and injectable preparations. This technical article explains the underlying chemistry, the step-by-step ChP assay procedure, the calculation of assay results, critical control points, and practical answers to frequently asked questions for quality-control laboratories.

Technical Overview

Mannitol is a hexahydric sugar alcohol (hexitol) with the molecular formula C6H14O6 and a molecular weight of 182.17 g/mol. It is a white, crystalline, non-hygroscopic powder, freely soluble in water, and is widely used both as an active pharmaceutical ingredient (an osmotic diuretic for reducing intracranial and intraocular pressure) and as a pharmaceutical excipient (tablet diluent, chewable-tablet sweetener, and lyophilization bulking agent).

The Chinese Pharmacopoeia (ChP), including the current 2020 Edition (Volume II), establishes the official assay for mannitol content in the monograph for mannitol and in the monographs for its preparations. The method is a classical periodate oxidation coupled with an indirect iodometric back-titration: mannitol is oxidized by sodium periodate in a dilute sulfuric acid medium, the excess periodate liberates iodine from potassium iodide, and the liberated iodine is titrated with sodium thiosulfate volumetric solution (0.05 mol/L) using starch as indicator. Each milliliter of 0.05 mol/L sodium thiosulfate VS is equivalent to 0.9109 mg of C6H14O6. For the API, the acceptance criterion is not less than 98.0% calculated on the dried basis; for mannitol injection, the content is typically required to be within 95.0% to 105.0% of the labeled amount.

This titrimetric approach is rooted in the classical Malaprade reaction, the periodate cleavage of vicinal diols first described in 1928, and it has remained essentially unchanged across successive ChP editions because of its robustness, high stoichiometric accuracy, and independence from expensive instrumentation.

Testing Samples

Mannitol Active Pharmaceutical Ingredient (Bulk Substance)

The primary sample type is the crystalline mannitol API itself. A portion of about 0.2 g, accurately weighed to 0.1 mg, is dissolved in water and diluted to 250 mL, after which an aliquot is taken for the periodate titration. Because mannitol is not hygroscopic, sample handling is straightforward, and results are reported on the dried basis by correcting for the separately determined loss on drying.

Mannitol Injection (Intravenous Infusion Solution)

Mannitol injection, commonly supplied as a 20% w/v solution (20 g per 100 mL) in large-volume containers, is assayed by taking an accurately measured volume equivalent to about 0.2 g of mannitol, diluting it to 250 mL with water, and proceeding with the identical periodate titration. The result is expressed as a percentage of the labeled amount. Crystallization observed in stored injections must be redissolved by warming with thorough mixing before sampling.

Excipient-Grade Mannitol and Finished Dosage Forms

Mannitol used as an excipient in tablets, granules, and lyophilized powders can also be assayed with this method. The sample is ground, extracted with water, and any insoluble matrix components are removed by filtration before dilution and titration. The same chemistry supports content-uniformity testing of individual dosage units, provided the unit potency falls within the validated working range of the titration.

Testing Items

Although the content assay is the focus of this article, it is performed as part of the full battery of tests defined in the ChP monograph, which together guarantee identity, purity, and strength:

• Identification: infrared absorption spectrum concordant with the reference standard, characteristic chemical reactions, and melting range (approximately 166 to 170 degrees Celsius).
• Assay (content of C6H14O6): not less than 98.0% on the dried basis for the API.
• Acidity or alkalinity, and clarity and color of the aqueous solution.
• Inorganic limit tests, including chlorides, sulfates, and oxalates at pharmacopoeial limit concentrations.
• Loss on drying and residue on ignition under the conditions specified in the monograph.
• Tests relevant to parenteral use, such as bacterial endotoxins and, where applicable, sterility and particulate matter for injections.
• Fill volume, content uniformity, or related preparation-specific tests for finished dosage forms.

Testing Methods

Principle and Stoichiometry of the Official Assay

Under acidic conditions, sodium periodate selectively cleaves carbon-to-carbon bonds bearing adjacent hydroxyl groups (vicinal diols). Mannitol, a linear hexitol containing five such adjacent hydroxyl pairs, is completely oxidized according to the net reaction: one mole of mannitol consumes five moles of periodate, yielding two moles of formaldehyde and four moles of formic acid. The unreacted, excess periodate then oxidizes iodide to iodine in a one-to-one molar ratio, and the liberated iodine is titrated with sodium thiosulfate, where one mole of iodine consumes two moles of thiosulfate. Combining these relationships, one mole of mannitol corresponds stoichiometrically to ten moles of sodium thiosulfate. Consequently, each milliliter of 0.05 mol/L sodium thiosulfate VS, corrected by its standardization factor, is equivalent to 0.9109 mg of C6H14O6 (0.05 millimole divided by 10, multiplied by 182.17 mg per millimole).

Reagents and Apparatus

• Sodium periodate mixed reagent: prepare freshly by combining 90 mL of dilute sulfuric acid (1 in 20) with 110 mL of sodium periodate solution (2.3 in 1000), and mix well.
• Potassium iodide test solution and starch indicator solution, prepared according to the ChP reagent chapters.
• Sodium thiosulfate volumetric solution (0.05 mol/L), standardized against the potassium dichromate reference standard with the molarity correction factor F recorded.
• Glassware: a 250 mL volumetric flask, a calibrated 10 mL pipette, glass-stoppered iodine flasks, a Class A burette, a constant-temperature water bath, and an analytical balance with 0.1 mg readability.

Step-by-Step Procedure Specified by the ChP

• Accurately weigh about 0.2 g of the test sample and transfer it to a 250 mL volumetric flask; dissolve in purified water, dilute to volume, and mix thoroughly.
• Pipette 10.0 mL of the sample solution into a dry iodine flask and accurately add 50.0 mL of the freshly prepared sodium periodate mixed reagent.
• Heat the stoppered flask in a water bath for 15 minutes to complete the oxidation, then cool to room temperature.
• Add 10 mL of potassium iodide test solution, immediately insert the stopper, mix, protect from light, and allow to stand for 5 minutes so that iodine is quantitatively liberated.
• Titrate with sodium thiosulfate VS (0.05 mol/L); when the solution turns pale yellow (near the endpoint), add 1 mL of starch indicator solution and continue the titration dropwise until the blue color just disappears.
• Perform a blank determination in the same manner, substituting 10 mL of water for the sample solution, and correct the titration result with the blank value.

Calculation of Assay Content

The mannitol content as a percentage is calculated as: Content (%) = (V0 minus V) multiplied by F, multiplied by 0.9109 mg/mL, multiplied by the dilution factor 25 (250 mL divided by the 10 mL aliquot), divided by the sample weight W in milligrams, multiplied by 100. In this expression, V0 is the blank titration volume in mL, V is the sample titration volume in mL, and F is the concentration correction factor of the titrant relative to 0.05 mol/L. The result on the as-is basis is converted to the dried basis by dividing by (1 minus the fraction of loss on drying). For injections, the assayed concentration in mg/mL is compared directly with the labeled concentration and reported as a percentage of label claim.

Critical Control Points and Precautions

• Prepare the periodate reagent freshly, because periodate slowly decomposes in dilute acid, which would inflate the blank and distort the difference titration.
• Strictly observe the 15-minute water-bath heating time; incomplete oxidation of mannitol leads to systematically low results.
• Keep the iodine flask stoppered and protected from light between iodide addition and titration to prevent loss of iodine by volatilization or photolysis.
• Add the starch indicator only near the endpoint, since excessive contact of iodine with starch slows the desorption of iodine and can prolong or bias the endpoint.
• Standardize the sodium thiosulfate solution at appropriate intervals and always apply the correction factor F.
• Run a blank with every analytical series, as the blank absorbs reagent background and is essential to the accuracy of the difference calculation.
• Guard against positive interference from other polyols and vicinal diols (for example glycerol, sorbitol, or ethylene glycol) in solvents, cleaning residues, or the sample matrix, all of which consume periodate.

Complementary and Alternative Analytical Techniques

While the periodate titration remains the official and authoritative ChP method, laboratories frequently apply chromatographic and other techniques for research, in-process control, or complex multi-component matrices. These include high-performance liquid chromatography with refractive index detection, HPLC with evaporative light-scattering detection on carbohydrate or hydrophilic interaction columns, high-performance anion-exchange chromatography with pulsed amperometric detection (particularly effective for separating mannitol from sorbitol and other sugar alcohols), enzymatic assay kits, quantitative NMR, and near-infrared spectroscopy with chemometric calibration for rapid release testing. Any alternative method intended for regulatory release must be fully validated for accuracy, precision, specificity, linearity, range, and robustness, and its equivalence to the pharmacopoeial titration must be demonstrated.

Applications

The ChP mannitol assay is applied throughout the product lifecycle in pharmaceutical manufacturing and testing. Routine quality-control laboratories use it for incoming-material qualification of excipient-grade mannitol and for batch release of the API and mannitol injection against the monograph acceptance criteria.

• Batch release and stability testing of mannitol API and mannitol injections under ICH long-term, intermediate, and accelerated storage conditions.
• Process development and manufacturing support for mannitol produced by catalytic hydrogenation of fructose or glucose syrups, where titrimetric potency confirms conversion completeness and batch consistency.
• Excipient qualification for direct-compression tablet diluents, chewable formulations, and lyophilized injectable products where mannitol serves as a crystalline or amorphous cake-forming bulking agent.
• Regulatory dossier support, including pharmacopoeial compliance for product registration, import and export testing, and post-approval change verification.
• Content-uniformity and unit-dose verification for low-strength solid dosage forms, where the sample quantity is adjusted to remain within the working range of the titration.

FAQ

Question: Why does each milliliter of 0.05 mol/L sodium thiosulfate correspond to exactly 0.9109 mg of mannitol?

Answer: The titer follows directly from the combined stoichiometry. One mole of mannitol consumes five moles of periodate in the Malaprade oxidation. Each mole of excess periodate liberates one mole of iodine from potassium iodide, and each mole of iodine consumes two moles of thiosulfate. Therefore one mole of mannitol is equivalent to ten moles of thiosulfate, and 0.05 millimole per milliliter divided by ten, multiplied by 182.17 mg per millimole, gives 0.9109 mg per milliliter.

Question: Why is a blank determination mandatory?

Answer: The blank titrates the same periodate reagent without the sample and therefore captures the iodine generated by the entire reagent system itself. Subtracting the blank from the sample titration isolates the periodate consumed solely by mannitol, which is the basis of the difference calculation. Omitting the blank makes the result meaningless.

Question: What are the acceptance criteria for the assay?

Answer: For mannitol API, the ChP requires not less than 98.0% of C6H14O6 calculated on the dried basis. For mannitol injection, the content must generally fall within 95.0% to 105.0% of the labeled amount. Individual compound-preparation monographs should always be consulted for their specific limits.

Question: Which substances interfere with the method?

Answer: Any compound containing vicinal diol groups or otherwise reducible by periodate, including sorbitol, glycerol, ethylene glycol, glucose, and other reducing sugars, will consume periodate and bias the result upward. This is precisely why the monograph pairs the assay with limit tests for related sugars and polyols and with identity testing.

Question: Is the ChP method consistent with other pharmacopoeias?

Answer: The periodate oxidation and thiosulfate titration chemistry is shared internationally; for example, the USP employs the same reaction principle with a sodium thiosulfate volumetric solution of double the concentration, which yields a proportionally doubled titer. Minor differences in reagent concentrations and units exist, so laboratories testing for multiple markets must follow each pharmacopoeia's exact procedure.

Question: Can HPLC replace the titration for routine release testing?

Answer: Under the ChP, the periodate titration is the official method for release. Chromatographic methods such as HPLC-RI, HPLC-ELSD, or HPAEC-PAD may be used for research, in-process monitoring, or complex formulations, but a laboratory wishing to use them for regulatory release must validate the method comprehensively and demonstrate equivalence to, or justified superiority over, the pharmacopoeial procedure.

Question: What operational detail most often causes out-of-specification results?

Answer: The most common causes are an aged periodate reagent, insufficient heating time on the water bath, iodine loss from an unstoppered flask, and an unstandardized titrant. Controlling reagent freshness, the 15-minute heating step, light protection, and titrant standardization eliminates the majority of assay deviations in practice.